title: Canadian Journal of Ophthalmology Lecture: translational research advances in glaucoma neuroprotection.
abstract: Given that glaucoma is a disease of the central nervous system, there must be greater emphasis and focus on developing intraocular pressure-independent therapies. In addition, scientific research investigating the role of sustained drug delivery is critical for advancing the field. Exciting innovation will require close collaboration and full integration of clinical and basic research efforts. Thus, translational research advances in neuroprotection may lead to future development of truly revolutionary therapies for glaucoma (e.g., neuroregeneration).
authors.affiliation: Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Conn, USA. james.tsai@yale.edu
authors.forename: James C
authors.initials: JC
authors.lastname: Tsai
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D018463:Filtering Surgery; D005902:Glaucoma, Open-Angle / Q000517:prevention & control*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009901:Optic Nerve Diseases / Q000517:prevention & control*; D057170:Translational Research, Biomedical
chemical_list: D000959:Antihypertensive Agents; D018696:Neuroprotective Agents